Form 4 for DGX Quest Diagnostics
Accepted 2026-09-03 17:05:30 ET · period of report 2026-09-01 · accession 0001599837-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-03 17:05 | 2026-09-01 | DGX | Davis J. E. | CEO, Pres, Dir | S - Sale | $242.72 | -10.0K | 122.4K | -8% | -$2.43M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-01 | S | D | 10,000 | $242.72 | 122,423 | D | — | — | (F1) This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. |